Eagle’s Eye View: Top Takeaways from ACC.26

In this week’s View, Dr. Eagle highlights trials from the recently held ACC Scientific Sessions which took place in New Orleans, March 28-30. Important studies discussed include:

  • CHAMPION-AF: Left atrial appendage closure vs. anticoagulation for AFib
  • VESALIUS-CV: Evolocumab reduces CV risk in diabetic patients without ASCVD
  • Ez-PAVE: Hitting lower LDL-C target reduces major CV events
  • PRO-TAVI: Should high-risk patients undergo PCI before TAVI?
  • SMART-DECISION: Discontinuing beta-blockers safe 1 year post MI For stable patients
  • GoFreshRx: How home-delivered DASH groceries improve blood pressure (BP) and LDL-C
  • THRIVE: Exploring the positive effects of a culturally tailored “food-is medicine” program on lowering BP

X Links:

Resources

Clinical Topics: Arrhythmias and Clinical EP, Cardiac Surgery, Dyslipidemia, Invasive Cardiovascular Angiography and Intervention, Prevention, Valvular Heart Disease, Vascular Medicine

Keywords: EaglesEyeView